Quantum-Si
Quantum-Si specializes in single-molecule proteomics technology and offers the Platinum® benchtop sequencer for protein sequencing.
Single-Molecule Proteomics Technology
Quantum-Si specializes in single-molecule proteomics technology. This advanced field focuses on analyzing proteins at the most granular level, examining each molecule individually. The company's technology aims to revolutionize protein analysis by providing unprecedented accuracy and detail, which are critical for various scientific and medical research applications.
Platinum® Benchtop Sequencer
Quantum-Si offers the Platinum® benchtop sequencer, a powerful tool for protein sequencing. This instrument is designed to provide high-resolution data for a range of applications, including antibody characterization, biomarker identification, protein identification, protein variant analysis, and post-translational modification (PTM) analysis. The Platinum® sequencer was commercially launched in 2024.
Proprietary Semiconductor Chip
Quantum-Si has developed a proprietary semiconductor chip that enables next-generation single-molecule protein sequencing. This technology forms the backbone of their advanced proteomics solutions and is instrumental in achieving high precision and efficiency in protein analysis. The chip's development represents a significant milestone in the field of proteomics.
Platinum® Analysis Software Upgrades
Quantum-Si announced significant upgrades to its Platinum® Analysis Software to enhance data output and precision while reducing processing time. These improvements aim to provide users with more accurate and faster results, optimizing the overall experience and utility of the Platinum® benchtop sequencer.
NASDAQ Listing and Ticker Symbol QSI
Quantum-Si began trading on NASDAQ in June 2021, under the ticker symbol QSI. This milestone marked the company's entry into the public market and provided a platform for broader investment and growth opportunities. The listing highlights Quantum-Si's commitment to advancing its proteomics technology on a larger scale.
San Diego Product Development and Operations Facility
In 2022, Quantum-Si opened a new product development and operations facility in San Diego, California. This facility aims to bolster the company's research, development, and operational capabilities, supporting the advancement of its innovative proteomics technologies and expanding its capacity for production and innovation.